Latanoprost
RxNorm 43611
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 43611 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: latanoprost.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Latanoprost
(Atom ID: 502896)
PTPrescribable
Designated preferred name (PT):
Latanoprost
(Atom ID: 502901)
FNPrescribable
Full form of descriptor (FN):
Latanoprost (substance)
(Atom ID: 502906)
PTPrescribable
Designated preferred name (PT):
Latanoprost-containing product
(Atom ID: 10805831)
FNPrescribable
Full form of descriptor (FN):
Product containing latanoprost (medicinal product)
(Atom ID: 9724738)
Patient Education
Latanoprost Ophthalmic
Latanoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Latanoprost is in a class of medications called prostaglandin analogs. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.
[Learn More]
* Please review the disclaimer below.